What Does the Research Say About Medical Ozone?
Medical ozone is an area that tends to generate very strong opinions.
Depending on where you look, you may encounter claims that ozone is useful for an extraordinary number of conditions — or claims that there is no research supporting its medical use at all.
Neither description does a particularly good job of representing the scientific literature.
There is published research on medical ozone, including laboratory research, human physiological studies, clinical trials, systematic reviews, and meta-analyses.
But the strength of that evidence varies considerably depending on what is being studied, how ozone is administered, what outcome is measured, and the quality of the research itself.
So rather than asking:
“Does ozone work?”
a better scientific question is:
“What exactly has been studied, and how strong is the evidence for that particular question?”
First: What Is Medical Ozone?
Ozone — O₃ — is a molecule made of three oxygen atoms.
It is also a powerful oxidizing molecule.
When most people hear the word ozone, they think of atmospheric ozone or air pollution. That is an important distinction because inhaling ozone can irritate and damage the respiratory system.
Medical ozone research involves controlled concentrations of an oxygen-ozone mixture used through specific methods rather than breathing ozone into the lungs.
Published research has examined several very different approaches, including local injections, exposure of blood to an oxygen-ozone mixture outside the body before the blood is returned, and other routes used in research or clinical practice in various countries.
These methods should not automatically be treated as interchangeable.
A study involving an injection into a joint, for example, cannot tell us whether a systemic method produces the same result.
Route, concentration, protocol, population, and outcome all matter.
Why Would Researchers Study an Oxidizing Molecule?
At first glance, using an oxidant therapeutically can sound contradictory.
We often hear that oxidative stress is harmful, so why would scientists deliberately investigate a controlled oxidative stimulus?
This relates to a concept called hormesis.
Hormesis describes the idea that a small, controlled stressor can sometimes trigger an adaptive response from the body.
Exercise is a familiar example. Exercise temporarily creates cellular stress, but the body's response to that stress contributes to many of the adaptations associated with training.
Researchers studying medical ozone have proposed a somewhat similar concept.
When ozone comes into contact with biological fluids, it reacts rapidly and produces secondary molecules, including reactive oxygen species and lipid oxidation products.
Researchers have investigated whether these temporary signals may influence cellular pathways involved in the body's own antioxidant and inflammatory responses.
One pathway that appears frequently in the ozone literature is Nrf2 (Nuclear factor erythroid 2–related factor 2), which can be described as a cellular “master switch” that activates antioxidant and protective stress-response pathways, regulating cellular responses to oxidative stress.
That makes ozone biologically interesting.
But this is where our previous discussion about evidence becomes important:
A plausible mechanism does not prove a clinical benefit.
Understanding what happens to a signalling pathway in a laboratory is different from demonstrating that an intervention meaningfully improves health outcomes in people.
What Does the Human Research Look Like?
The answer is: mixed.
Some areas have been studied considerably more than others.
A 2022 review published in Frontiers in Physiology examined the literature surrounding medical ozone in pain medicine. The review included clinical trials, systematic reviews, and meta-analyses involving several musculoskeletal applications.
The authors considered the evidence surrounding knee osteoarthritis and lumbar disc herniation stronger than the evidence for many of the other applications discussed in the paper.
That does not mean Health Canada has determined that medical ozone is an authorized treatment for either condition.
It means that, within the literature reviewed by those authors, those were areas in which a larger and more developed body of clinical research existed.
That distinction matters.
Knee Osteoarthritis Has Been Studied — But the Research Is Not One Single Answer
Medical ozone has been investigated in people with knee osteoarthritis using intra-articular injection.
The literature includes randomized trials and several systematic reviews and meta-analyses.
Different studies have compared ozone with placebo, hyaluronic acid, and other approaches.
Results have not been identical.
Some studies reported improvements in pain or function, while comparative studies have sometimes favoured another intervention or found little meaningful difference between treatments.
Researchers have also used different concentrations, numbers of treatments, patient populations, and outcome measurements.
That makes it difficult to reduce the literature to a headline such as:
“Ozone works for arthritis.”
The more accurate statement is:
Medical ozone has been studied for knee osteoarthritis, including in randomized clinical trials and systematic reviews, but interpretation depends on the study design, comparator, protocol, and outcome being measured.
What About Low Back Pain and Disc Herniation?
This is another comparatively well-studied area within the ozone literature.
Researchers have investigated paravertebral and intradiscal approaches in people with lumbar disc herniation and associated pain.
The published literature includes randomized trials as well as systematic reviews and meta-analyses.
Again, however, that does not make every study equivalent.
Injection location differs.
Protocols differ.
Ozone concentrations differ.
Some studies compare ozone with another procedure, while others compare it with sham treatment or examine patients retrospectively.
And importantly, research involving an intradiscal procedure cannot simply be generalized to every other form of medical ozone.
This is one of the recurring challenges in interpreting ozone research.
Some Human Research Is Much More Preliminary
Other areas of ozone research are based on much smaller studies.
For example, one early study investigated cerebral and carotid blood flow in only seven people.
Researchers observed changes in blood-flow measurements following ozone autohemotherapy, but even the authors described the work as a preliminary report and stated that further clinical evaluation was needed.
Another prospective study examined muscle oxygenation in 23 patients and three volunteers.
The overall change in muscle oxygenation was not statistically significant, although researchers observed changes in some measures involving more poorly oxygenated tissue.
These studies are interesting because they explore possible physiological effects.
But they are very different from large randomized trials demonstrating meaningful clinical outcomes.
This is exactly why the type of evidence matters.
And Then There Are Case Reports
One of the papers in the ozone literature describes a single 75-year-old patient with cerebral ischemia and hypometabolism following previous treatment for a meningioma.
Changes were observed on some imaging and functional measures following ozone therapy, while MRI and CT findings did not change.
That may generate a research question.
It cannot tell us that ozone treats stroke, brain injury, or cerebral ischemia.
One person is not a clinical trial.
Case reports can identify interesting observations, but they cannot establish cause and effect or tell us how consistently an outcome would occur in other people.
What About Ozone and Inflammation?
Inflammation appears throughout the ozone literature.
Researchers have proposed that controlled oxidative signalling may influence pathways involved in inflammatory regulation, including interactions between Nrf2 and NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) signalling (helps regulate inflammation and immune responses).
This is scientifically interesting because these pathways participate in the body's response to oxidative stress and inflammation.
However, saying:
“Researchers have observed changes in inflammatory signalling pathways”
is not the same as saying:
“Ozone reduces inflammation in people.”
The first describes a research observation or proposed mechanism.
The second is a clinical claim.
Good science requires us to keep those statements separate.
Is Medical Ozone an Antioxidant or an Oxidant?
Technically, ozone itself is an oxidant.
This is another area where online explanations can become confusing.
Some researchers propose that a carefully controlled oxidative stimulus can activate the body's endogenous antioxidant defence systems.
That does not transform ozone itself into an antioxidant.
A more accurate description is that researchers are investigating whether controlled oxidative signalling can stimulate adaptive antioxidant responses.
Again, the concept is related to hormesis (the biological principle that a small, controlled dose of stress can stimulate the body to adapt and become more resilient, while too much of the same stress can cause harm).
And again, demonstrating a biochemical response does not automatically establish a clinical benefit.
Is Ozone Research Standardized?
Not particularly — and this is one of the biggest limitations in the literature.
The 2022 review itself identifies lack of standardized treatment protocols as a major weakness in ozone research.
Studies have used different concentrations, volumes, routes, frequencies, treatment schedules, comparators, and patient-selection criteria.
That creates a major problem when researchers try to combine studies.
If five studies all use something called “ozone therapy” but use substantially different procedures, we have to be very careful about treating them as though they studied the same intervention.
The authors of the 2022 review concluded that additional randomized controlled trials are needed.
What About Safety?
What About Safety?
Safety findings in ozone research vary considerably depending on how ozone is administered, the concentration used, the procedure being studied, the patient population, and the clinical setting. Published literature includes both minor adverse effects and uncommon serious complications.
For this reason, safety findings need to be interpreted in the context of the specific method of administration being studied. Findings from one method cannot necessarily be generalized to another.
Ozone exposure through the lungs is a separate consideration. Inhaled ozone is a respiratory irritant, and Health Canada identifies exposure to ozone in air as capable of causing effects including coughing, throat and chest irritation, shortness of breath, and decreased lung function.
As with effectiveness, the safety evidence should therefore be evaluated according to the particular procedure, route of administration, and research being discussed.
What About Research on Infections, COVID-19, Aging, or Neurodegenerative Disease?
There are publications exploring all of these areas.
But their existence should not be confused with established clinical evidence.
Some are mechanistic papers.
Some involve animal or laboratory research.
Some are reviews proposing hypotheses.
Some are uncontrolled clinical reports.
And some publications make conclusions that are substantially stronger than the underlying study design can support.
For example, a proposed interaction between ozone and the Nrf2 pathway does not establish that ozone prevents neurodegenerative disease.
Similarly, laboratory evidence involving viruses does not establish that systemic ozone therapy treats a viral infection in humans.
These are precisely the situations in which mechanism, hypothesis, and demonstrated clinical outcome must be kept separate.
Research Publication Is Not the Same as Regulatory Authorization
This distinction is especially important in Canada.
A treatment can be investigated internationally without Health Canada having authorized a specific health product or medical device for that purpose.
Likewise, a paper may describe a device as complying with European regulations.
That does not establish that the same device is licensed by Health Canada or that a particular therapeutic claim is authorized in Canada.
Canadian regulatory status must be assessed independently for the specific product, device, and representation being made.
Scientific publication and regulatory authorization answer different questions.
So… What Does the Evidence Actually Say?
Medical ozone has a substantial body of published research literature of varying quality and maturity. Some applications have been investigated in controlled human studies and systematic reviews, while many others remain preliminary, inconsistent, mechanistic, or insufficiently studied.
Overall, the evidence is best interpreted by indication, route of administration, study design, and quality of the available research.
Research & Education Notice
This article discusses published scientific research for general educational purposes. It is not intended to advertise or recommend a particular health product, medical device, procedure, or treatment, and should not be interpreted as medical advice or a guarantee of outcome.
The existence of published research or use of a product or device in another country does not establish that a specific health product, medical device, indication, or therapeutic claim has been authorized by Health Canada. Canadian authorization is specific to the individual product or device and its authorized terms of use.
Selected Research
Hidalgo-Tallón FJ, Torres-Morera LM, Baeza-Noci J, Carrillo-Izquierdo MD, Pinto-Bonilla R. Updated Review on Ozone Therapy in Pain Medicine. Frontiers in Physiology. 2022;13:840623. doi:10.3389/fphys.2022.840623.
Clavo B, Catalá L, Pérez JL, Rodríguez V, Robaina F. Ozone Therapy on Cerebral Blood Flow: A Preliminary Report. Evidence-Based Complementary and Alternative Medicine. 2004;1(3):315–319. doi:10.1093/ecam/neh039.
Clavo B, Pérez JL, López L, et al. Effect of Ozone Therapy on Muscle Oxygenation. Journal of Alternative and Complementary Medicine. 2003;9(2):251–256.
Comments